Telmisartan, ramipril, or both in patients at high risk for vascular events by ONTARGET Investigators, Yusuf Salim, Teo Koon K, Pogue Janice, Dyal Leanne, Copland Ingrid, Schumacher Helmut, Dagenais Gilles, Sleight Peter, Anderson Craig in The New England journal of medicine (2008).

[PMID: 18378520] PubMed


Discussed In Paper


Dosing Information

No dosing information annotated.